Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3.

The effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2)D3], a steroid hormone with immunomodulating properties, on nuclear factor kappa B (NF-kappa B) proteins was examined in in vitro activated normal human lymphocytes by Western blot analysis. Over a 72-hr period of activation, the expression of the 50-kDa NF-kappa B, p50, and its precursor, p105, was increased progressively. When cells were activated in the presence of 1,25(OH)2D3, the levels of the mature protein as well as its precursor were decreased. The effect of the hormone on the levels of p50 was demonstrable in the cytosolic and nuclear compartments; it required between 4 and 8 hr and was specific, as 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were ineffective. Besides p50, 1,25(OH)2D3 decreased the levels of another NF-kappa B protein, namely c-rel. In addition, 1,25(OH)2D3 decreased the abundance of a specific DNA-protein complex formed upon incubation of nuclear extracts from activated lymphocytes with a labeled NF-kappa B DNA binding motif. Further, 1,25(OH)2D3 inhibited the transcriptional activity of NF-kappa B in Jurkat cells transiently transfected with a construct containing four tandem repeats of the NF-kappa B binding sequence of the immunoglobulin kappa light chain gene linked to the chloramphenicol acetyltransferase reporter gene. These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.

[1]  S. Manolagas,et al.  Vitamin D receptor expression in human lymphocytes. Signal requirements and characterization by western blots and DNA sequencing. , 1991, The Journal of biological chemistry.

[2]  N. Rice,et al.  The v-rel and c-rel proteins exist in high molecular weight complexes in avian and murine cells. , 1991, Oncogene.

[3]  S. Perkins,et al.  Age-related bone loss. A hypothesis and initial assessment in mice. , 1995, Clinical orthopaedics and related research.

[4]  C. Scheidereit,et al.  Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli , 1991, Molecular and cellular biology.

[5]  C. Scheidereit,et al.  Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[7]  M. Karin,et al.  Molecular Cloning and Characterization of a Novel Rel/NF-χB Family Member Displaying Structural and Functional Homology to NF-χB p50/p105 , 1992 .

[8]  K. Yamamoto,et al.  Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. , 1990, Science.

[9]  T. Hunter,et al.  Transcriptional induction of the murine c-rel gene with serum and phorbol-12-myristate-13-acetate in fibroblasts , 1989, Molecular and cellular biology.

[10]  G. Nolan,et al.  The inhibitory ankyrin and activator Rel proteins , 1992, Current Biology.

[11]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[12]  P. Baeuerle,et al.  The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. , 1993, The Biochemical journal.

[13]  P. Kourilsky,et al.  The characterization of the promoter of the gene encoding the p50 subunit of NF‐kappa B indicates that it participates in its own regulation. , 1992, The EMBO journal.

[14]  S. Manolagas,et al.  Vitamin D and the hematolymphopoietic tissue: a 1994 update. , 1994, Seminars in nephrology.

[15]  David,et al.  17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. , 1994, The Journal of clinical investigation.

[16]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[17]  M. Brach,et al.  Inhibition of EGR-1 and NF-kappa B gene expression by dexamethasone during phorbol ester-induced human monocytic differentiation. , 1992, Biochemical pharmacology.

[18]  A. Semerjian,et al.  Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner. , 1991, Transplantation proceedings.

[19]  M. Grilli,et al.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. , 1993, International review of cytology.

[20]  A. Israël,et al.  The precursor of NF-κB p50 has IκB-like functions , 1992, Cell.

[21]  G. Nolan,et al.  Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal , 1990, Cell.

[22]  L. Rawlinson,et al.  Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. , 1992, The Journal of biological chemistry.

[23]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[24]  Vincent Bours,et al.  Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs , 1990, Nature.

[25]  S. Manolagas,et al.  Interactions of 1,25-dihydroxyvitamin D3 and the immune system , 1985, Molecular and Cellular Endocrinology.